Company profile: Rx Redefined
1.1 - Company Overview
Company description
- Provider of a compliance-focused DMEPOS platform for physician-owned suppliers, covering licensing; electronic ordering to reduce paperwork and streamline ordering; distribution center integration for timely delivery; end-to-end billing and audit management; and Compliance-as-a-Service to ensure and document regulatory compliance, while enabling physician and patient product choice without third-party interference.
Products and services
- DMEPOS Platform: A compliance-focused platform for physician-owned DMEPOS suppliers that architects licensing workflows, orchestrates electronic order processing, and produces billing records to ensure documented regulatory compliance for each order
- Compliance-as-a-Service: A compliance-focused product that ensures and documents regulatory compliance with each order, creating auditable records per transaction for DMEPOS suppliers
- Billing & Audit Management: An end-to-end service that manages revenue cycles and performs routine audits for DMEPOS suppliers, consolidating billing operations and audit activities for consistent financial control
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Rx Redefined
Surgical Notes
HQ: United States
Website
- Description: Provider of healthcare IT solutions for ambulatory surgery centers, offering enterprise revenue cycle solutions to maximize profitability and physician disbursements: revenue cycle management (SNBilling Team), web-based transcription (SNChart), full-service coding and audits (SNCoder), document management and chart digitization (ScanChart ASC), and a central billing office workflow tool (ScanChart CBO).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Surgical Notes company profile →
Sterifre
HQ: United States
Website
- Description: Provider of a proprietary low-cost plug-and-play technology platform for automated disinfection of non-critical medical devices, featuring the AURA Disinfection System using hydrogen peroxide and activated oxygen, aiming to reduce pathogen exposure and chemical use, and the AURA-D Cartridge, a consumable designed to replace up to 60 canisters of disinfectant wipes, reducing environmental impact.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sterifre company profile →
Kobus
HQ: France
Website
- Description: Provider of a digital assistant that facilitates the daily life of physiotherapists.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kobus company profile →
Pieces
HQ: United States
Website
- Description: Provider of healthcare artificial intelligence and technology solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pieces company profile →
Doceree
HQ: United States
Website
- Description: Provider of marketing solutions for pharmaceutical and healthcare brands to connect with HCPs, including ESPYIANTM for AI- and data-driven HCP identification and targeting, Clinical Triggers for targeting at specific moments in care delivery, a full DSP/SSP/Ad Server/DMP stack for programmatic marketing, a Real-time Performance Dashboard, Co-Pay Spark to boost reach, awareness, and copay solution utilization to prevent prescription abandonment, and intent-based audience tools for Account-based Marketing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Doceree company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Rx Redefined
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Rx Redefined
2.2 - Growth funds investing in similar companies to Rx Redefined
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Rx Redefined
4.2 - Public trading comparable groups for Rx Redefined
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →